Malaria Vaccines Market Overview, Analysis and Insights
- Get link
- Other Apps
According to World Health Organization statistics, about half of the world's population is at risk of malaria (WHO). As a result, numerous healthcare organisations have been more interested in solving this serious problem. The Melinda Gates Foundation and PATH, two global non-profit organisations, are trying to develop malaria prevention techniques and save the lives of many people in malaria-affected areas. Because Africa accounts for 90% of malaria occurrences, the launch of GlaxoSmithKline plc's first malaria vaccine is aimed primarily at this continent. Mosquirix was approved by the European Union in 2015 and is currently being tested in Africa as part of a pilot project.
Insecticide-treated
mosquito nets and indoor insecticide spraying are used in Africa to combat
malarial vectors. Between 2010 and 2015, the use of insecticide-treated
mosquito nets in Africa climbed by 80%. (WHO). Furthermore, a variety of
mosquito repellent items (patches, lotions, coils, mats, liquids, and so on)
are sold all over the world. Furthermore, non-profit organisations give
low-cost or even free treatment to Africa's malaria-affected people. GSK has
also committed to selling the vaccinations at a substantially cheaper price,
foregoing its large profit margins in order to help worldwide malaria
eradication efforts. Furthermore, the malaria
vaccines market is primed for significant growth in the near future,
with new malaria vaccines in the pipeline.
Market Analysis and Insights
The global malaria
vaccines market is primarily driven by rising malaria incidence, an
increase in patient awareness, and government initiatives. Furthermore,
advancements in the pharmaceutical and biotechnology sectors or industries, as
well as an increase in vaccination demand, are some of the driving reasons for
market expansion. Nonetheless, a lack of income prospects, as well as high
treatment costs and technological challenges in creating vaccines, are some of
the major issues limiting the market's growth.
Market
share, new developments and product pipeline analysis, impact of domestic and
localised market players, opportunities in terms of emerging revenue pockets,
changes in market regulations, product approvals, strategic decisions, product
launches, geographic expansions, and technological innovations are all covered
in this report on the global malaria vaccines market. Contact us for an Analyst
Brief to better understand the study and market condition; our team will assist
you in developing a revenue impact solution to meet your objectives.
- Get link
- Other Apps
Comments
Post a Comment